We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Lugol's Solution Stabilized with PVP for Gram Stain

By LabMedica International staff writers
Posted on 03 Jan 2011
Lugol's solution is an aqueous solution, which contains iodine (I2) and potassium iodide (KI) in a ratio of 1:2.

Used for Gram staining, Lugol's iodine solution is required to form the dye-iodine complex of Gram-positive bacteria. More...
It can also be used as an antiseptic and disinfectant for emergency disinfection of drinking water, and as a reagent for starch detection in routine laboratory and other medical tests.

Stock solutions of I2 - KI in water are unstable. Iodine can be lost by evaporation and that can influence the result of the staining as well as affecting the working conditions in that area. Stainless steel parts of staining instruments can also be affected by the iodine in the Lugol's solution. If the concentration of iodine in the Lugol's solution decreases, the bacterial smears may become more susceptible to decolorization.

The problem of iodine loss can be overcome by using polyvinylpyrrolidine (PVP) in the I2 - KI solution. PVP forms a complex with iodine. This complex is more stable and has a longer shelf life. Material treated with Lugol's solution stabilized with PVP will give identical results with regard to differentiation of Gram-positive and Gram-negative bacteria compared to the standard Lugol's solution.

In the standard Gram procedure, the aniline dyes in the cell tissue of microorganisms form a red dye-iodine complex when exposed to iodine. In Gram-positive microorganisms, the dye-iodine complex cannot subsequently be dissolved from the cells by decolorizing agents such as alcohol or acetone. The cells remain dark blue in color. In Gram-negative microorganisms, the dye-iodine complex is dissolved and the cell turns red as a result of counterstaining.

Both Lugol's solutions (the standard type and the stabilized type) are available for bacteriological staining from Merck KGaA (Darmstadt, Germany), or EMD Chemicals (Gibbstown, NJ, USA) in the USA. Suitable protocols are available on the internet or on demand.

Related Links:
Merck KGaA
EMD Chemicals




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image: Graphical Abstract (Image Credit: Cheng N, Ouellette TW, Skead K, et al. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genomics (2026). DOI:10.1016/j.xgen.2026.101364)

Blood Test Stratifies Prostate and Breast Cancer Risk Years Before Diagnosis

Cancer is the second leading cause of death globally, and late diagnosis contributes substantially to mortality. Routine screening is available for only a few cancer types, while other early detection... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.